Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: A commentary

Pharmacogenomics

Volumn 7, Issue 3, 2006, Pages 521-528

  Demitrack, Mark A ^a  

^a Neuronetics   (United States)

Author keywords

Chronic fatigue syndrome; Clinical trial methods; Diagnosis; Outcome assessment; Therapeutics

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE RESISTANCE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; METHODOLOGY; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT SELECTION; SYMPTOM;

COMORBIDITY; FATIGUE SYNDROME, CHRONIC; HUMANS; TREATMENT OUTCOME;

EID: 33646020699     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.7.3.521     Document Type: Article

References (25)

1. Fukuda K, Straus SE, Hickie I et al.: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121, 953-959 (1994).
2. Henningsen P, Zimmerman T, Sattel H: Medically unexplained physical symptoms, anxiety and depression: a meta-analytic review. Psychosom. Med 65(4), 528-533 (2003).
3. Katon W, Russo J: Chronic fatigue syndrome criteria: a critique of the requirement for multiple physical complaints. Arch. Int. Med. 152(8), 1604-1609 (1992).
4. Allen LA, Gara MA, Escobar JI, Waitzkin H, Silver RC: Somatization: a debilitating syndrome in primary care. Psycosomatics 42(1), 63-67 (2001).
5. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J: An international study of the relation betweeen somatic symptoms and depression. N. Engl. J. Med. 341(18), 1329-1335 (1999).
6. Kroenke K, Spitzer RL, Williams JB et al.: Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch. Fam. Med. 3, 774-779 (1994).
7. White PD, Thomas JM, Amess J et al.: Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br. J. Psychiatry 173, 475-481 (1998).
8. Demitrack MA, Abbey SE: Historical Overview and Evolution of Contemporary Definitions of Chronic Fatigue States. In: Chronic Fatigue Syndrome: An Integrative Approach to Evaluation and Treatment, Demitrack MA, Abbey SE (Eds), Guilford Press, New York, NY, USA, 3-35 (1996).
9. Straus SE, Tosato G, Armstrong G et al.: Persisting illness and fatigue in adults with evidence of Epstein Barr virus infection. Ann. Int. Med. 102(1), 7-16 (1985).
10. Lloyd AR, Hickie I, Peterson PK: Chronic fatigue syndrome: current concepts of pathogenesis and treatment. Curr. Clin. Top. Infect. Dis. 19, 135-159 (1999).
11. Gerrity TR, Papanicolaou DA, Amsterdam JD et al.: Immunologic aspects of chronic fatigue syndrome: report on a research symposium convened by the CFIDS association of america and co-sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health. Neuroimmunomodulation 11(6), 351-357 (2004).
12. Demitrack MA, Dale JK, Straus SE et al.: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endo. Metab. 73(6), 1224-1234 (1991).
13. Lange G, Wang S, DeLuca J, Natelson BH: Neuroimaging in chronic fatigue syndrome. Am. J. Med. 105(3A), 50S-53S (1998).
14. Demitrack MA: Chronic fatigue syndrome and fibromyalgia: dilemmas in diagnosis and clinical management. Psychiatric. Clin. N. Amer. 21(3), 671-692 (1998).
15. Rimes KA, Chaider T. Treatments for chronic fatigue syndrome. Occup. Med. 55(1), 32-39 (2005).
16. Hamilton M: A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62 (1960).
17. Gibbons RD, Clark DC, Kupfer DJ: Exactly what does the hamilton depression rating scale measure? J. Psychiat. Res. 27(3), 259-273 (1993).
18. Rube HG, Dekker JJ, Peen J, Holman R, de Jonghe F: Clinical use of the hamilton depression rating scale: is increased efficiency possible? A post hoc comparison of hamilton depression rating scale, maier and bech subscales, clinical global impression, and symptom checklist-90 scores. Compr. Psychiatry 46(6), 417-427 (2005).
19. Demitrack MA, Faries D, Herrera JM, DeBrota D, Potter WZ: The problem of measurement error in multisite clinical trials. Psychopharm. Bull. 34(1), 19-24 (1998).
20. Williams JB: A structured interview guide for the hamilton depression rating scale. Arrh. Gen. Psychiatry 45(8), 742-747 (1988).
21. Sackeim HA: The definition and meaning of treatment resistance. J. Clin. Psychatry 62(Suppl. 16), 10-17 (2001).
22. Sackeim HA, Rush AJ, George MS et al.: Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharm. 25, 713-728 (2001).
23. Prudic J, Haskett RF, Mulsant B et al.: Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry 153(8), 985-992 (1996).
24. Thase ME, Rush AJ: When at first you don't succeed: sequential strategies for antidepressant nonresponders. J. Clin. Psychiatry 58(Suppl. 13), 23-29 (1997).
25. Cho HJ, Hotopf M, Wessely S: The placebo response in the treatment of chronic fatigue syndrome: a systemacti review and meta-analysis. Psychosom. Med. 67, 301-313 (2005).